Finance

Lists
Why is BAX down 2.94%?
Dive Deeper
BAX:NYSE
Baxter International Inc
$ 25.39
-2.94%
(-0.77) 1D
$ 25.59
+0.79% (+0.20)
Pre-market
Closed: 11-р сарын 19, 16:00:03 (GMT-5)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAX...
Open
$ 26.10
High
$ 26.16
Low
$ 25.13
Mkt. cap
13.14 тэрбум
Avg. vol.
6.59 сая
Volume
1.24 мян
Dividend
0.16%
Quarterly dividend
$ 0.01
Ex-dividend date
2026 оны 11-р сарын 27
52-wk high
$ 30.00
52-wk low
$ 15.73
EPS
-$ 1.42
Beta
0.68
Shares outstanding
517.35 сая
No. of employees
38 мян
Open
$ 26.10
High
$ 26.16
Low
$ 25.13
Mkt. cap
13.14 тэрбум
Avg. vol.
6.59 сая
Volume
1.24 мян
Dividend
0.16%
Quarterly dividend
$ 0.01
Ex-dividend date
2026 оны 11-р сарын 27
52-wk high
$ 30.00
52-wk low
$ 15.73
EPS
-$ 1.42
Beta
0.68
Shares outstanding
517.35 сая
No. of employees
38 мян
News stories
From web sources and news partners
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37.5 мян
Founded1931
HeadquartersDeerfield, Иллиной, Америкийн Нэгдсэн Улс
SectorHealth Care
Industry-
Websitebaxter.com
Analyst ratings
Based on 7 analysts giving stock ratings to BAX in the past 3 months
Hold
Buy
0
Hold
6
Sell
1
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BAX in the last 3 months.
Highest
Current $ 25.39
$ 27.00 (+6.34%)
Average
$ 25.00 (-1.54%)
Lowest
$ 23.00 (-9.41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Steven Silver
Argus Research
Hold
Maintained
-
-
11/11/2026
Unknown Analyst
Argus Research
Hold
Maintained
-
-
11/11/2026
Christopher Pasquale
Barclays
Sell
Maintained
$ 23.00
-9.4%
11/09/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
$ 25.00
-1.5%
10/30/2026
Rick Wise
Stifel Nicolaus
Hold
Maintained
$ 25.00
-1.5%
10/30/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$ 25.00
-1.5%
10/30/2026
Matthew Taylor
Jefferies
Hold
Maintained
$ 25.00
-1.5%
10/29/2026
Matt Miksic
Barclays
Sell
Maintained
$ 20.00
-21.2%
10/07/2026
Joanne Wuensch
Citi
Hold
Maintained
$ 27.00
+6.3%
10/05/2026
Travis Steed
Bank of America Securities
Hold
Maintained
$ 28.00
+10.3%
08/11/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
$ 27.00
+6.3%
07/31/2026
Josh Jennings
TD Cowen
Hold
Maintained
$ 29.00
+14.2%
07/31/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$ 23.00
-9.4%
07/31/2026
Danielle Antalffy
UBS
Hold
Reiterated
$ 25.00
-1.5%
07/28/2026
Patrick Wood
UBS
Hold
Reiterated
$ 25.00
-1.5%
07/28/2026
David Roman
Goldman Sachs
Hold
Reiterated
$ 21.00
-17.3%
07/15/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$ 24.00
-5.5%
07/06/2026
Last report
2026 оны 10-р сарын 29
Fiscal period
Q3 2026
$ 0.58 / $ 0.52
+11.92%beat
Revenue / Est. (USD)
2.98 тэрбум / 2.91 тэрбум
+2.33%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
2.97 тэрбум
2.70 тэрбум
2.96 тэрбум
2.98 тэрбум
Cost of goods sold
2.01 тэрбум
1.80 тэрбум
1.99 тэрбум
1.93 тэрбум
Cost of revenue
2.01 тэрбум
1.80 тэрбум
1.99 тэрбум
1.93 тэрбум
Research and development expenses
116.00 сая
124.00 сая
125.00 сая
118.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
675.00 сая
658.00 сая
693.00 сая
680.00 сая
Operating expense
741.00 сая
740.00 сая
766.00 сая
750.00 сая
Total operating expenses
2.76 тэрбум
2.54 тэрбум
2.75 тэрбум
2.68 тэрбум
Operating income
219.00 сая
158.00 сая
207.00 сая
294.00 сая
Other non operating income
3.00 сая
-1.00 сая
1.00 сая
-1.00 сая
EBT including unusual items
-756.00 сая
-6.00 сая
158.00 сая
417.00 сая
EBT excluding unusual items
161.00 сая
88.00 сая
144.00 сая
227.00 сая
Income tax expense
279.00 сая
11.00 сая
23.00 сая
119.00 сая
Effective tax rate
-36.90%
-183.33%
14.56%
28.54%
Other operating expenses
-50.00 сая
-42.00 сая
-52.00 сая
-48.00 сая
Net income
-1.13 тэрбум
-15.00 сая
126.00 сая
294.00 сая
Net profit margin
-37.93%
-0.56%
4.26%
9.88%
Earnings per share
0.44
0.36
0.56
0.58
Interest and investment income
11.00 сая
12.00 сая
13.00 сая
13.00 сая
Interest expense
-69.00 сая
-78.00 сая
-77.00 сая
-74.00 сая
Net interest expenses
-58.00 сая
-66.00 сая
-64.00 сая
-61.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
459.00 сая
395.00 сая
446.00 сая
533.00 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google аппс